Abstract: The present invention relates to a pharmaceutical formulation of 5-fluoropyrimidine derivatives or a salt, solvate, or hydrate thereof for oral administration wherein the formulation is a simple composition for ingestion, simple, safest, convenient, non-invasive, versatility and most importantly, the patient compliance for oral administration with improved compliance, safety, and bioavailability. Further disclosed is a process for the preparation, composition, methods of administration, dosages of the formulation and their use for treating cancers and its associated complications.
| # | Name | Date |
|---|---|---|
| 1 | 202247062161-FORM 3 [22-05-2023(online)].pdf | 2023-05-22 |
| 1 | 202247062161.pdf | 2022-11-01 |
| 2 | 202247062161-STATEMENT OF UNDERTAKING (FORM 3) [01-11-2022(online)].pdf | 2022-11-01 |
| 2 | 202247062161-FORM 3 [18-02-2023(online)].pdf | 2023-02-18 |
| 3 | 202247062161-PROOF OF RIGHT [01-11-2022(online)].pdf | 2022-11-01 |
| 3 | 202247062161-Form-1_24-11-2022.pdf | 2022-11-24 |
| 4 | 202247062161-COMPLETE SPECIFICATION [01-11-2022(online)].pdf | 2022-11-01 |
| 4 | 202247062161-PRIORITY DOCUMENTS [01-11-2022(online)].pdf | 2022-11-01 |
| 5 | 202247062161-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [01-11-2022(online)].pdf | 2022-11-01 |
| 5 | 202247062161-DECLARATION OF INVENTORSHIP (FORM 5) [01-11-2022(online)].pdf | 2022-11-01 |
| 6 | 202247062161-FORM FOR SMALL ENTITY(FORM-28) [01-11-2022(online)].pdf | 2022-11-01 |
| 6 | 202247062161-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [01-11-2022(online)].pdf | 2022-11-01 |
| 7 | 202247062161-FORM 1 [01-11-2022(online)].pdf | 2022-11-01 |
| 8 | 202247062161-FORM FOR SMALL ENTITY(FORM-28) [01-11-2022(online)].pdf | 2022-11-01 |
| 8 | 202247062161-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [01-11-2022(online)].pdf | 2022-11-01 |
| 9 | 202247062161-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [01-11-2022(online)].pdf | 2022-11-01 |
| 9 | 202247062161-DECLARATION OF INVENTORSHIP (FORM 5) [01-11-2022(online)].pdf | 2022-11-01 |
| 10 | 202247062161-COMPLETE SPECIFICATION [01-11-2022(online)].pdf | 2022-11-01 |
| 10 | 202247062161-PRIORITY DOCUMENTS [01-11-2022(online)].pdf | 2022-11-01 |
| 11 | 202247062161-Form-1_24-11-2022.pdf | 2022-11-24 |
| 11 | 202247062161-PROOF OF RIGHT [01-11-2022(online)].pdf | 2022-11-01 |
| 12 | 202247062161-STATEMENT OF UNDERTAKING (FORM 3) [01-11-2022(online)].pdf | 2022-11-01 |
| 12 | 202247062161-FORM 3 [18-02-2023(online)].pdf | 2023-02-18 |
| 13 | 202247062161.pdf | 2022-11-01 |
| 13 | 202247062161-FORM 3 [22-05-2023(online)].pdf | 2023-05-22 |